Logo 1 Logo 2

Clinical Trial Details

Trial ID: L3466
Source ID: NCT00071422
Associated Drug: Ingap-Peptide
Title: Safety and Efficacy of INGAP-Peptide in Patients With Type 2 Diabetes
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Diabetes Mellitus, Non-Insulin-Dependent
Interventions: DRUG: INGAP-Peptide|DRUG: INGAP-Peptide|DRUG: placebo
Outcome Measures:
Sponsor/Collaborators: Sponsor: Exsulin Corporation
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE2
Enrollment: 126
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Start Date: 2003-10
Completion Date: 2004-06
Results First Posted:
Last Update Posted: 2014-07-11
Locations: Diabetes and Endocrine Associates, La Jolla, California, 92037, United States|VA Hospital UCSD, San Diego, California, 92161, United States|Diablo Clinical Research, Walnut Creek, California, 94598, United States|Denver, Colorado, 80209, United States|Longmont Medical Research Network, Longmont, Colorado, 80501, United States|MedStar Clinical Research Center, Washington, District of Columbia, 20003, United States|Future Care Studies, Springfield, Massachusetts, 01107, United States|Mercury Street Medical, Butte, Montana, 59701, United States|Diabetes-Endocrinology Center of WNY, Buffalo, New York, 14209, United States|UNC Diabetes Care Center, Durham, North Carolina, 27713, United States|Piedmont Medical Group, Winston-Salem, North Carolina, 27103, United States|Clinical Research Institute of Southern Oregon, Medford, Oregon, 97504, United States|Mountain View Clinical Research, Greer, South Carolina, 29651, United States|Dallas Diabetes and Endocrine Center, Dallas, Texas, 75230, United States|University of Texas Health Science Center - Texas Diabetes Institute, San Antonio, Texas, 78207, United States|DGD Research Associates, San Antonio, Texas, 78229, United States|Charlottesville Medical Research, Charlottesville, Virginia, 22911, United States
URL: https://clinicaltrials.gov/show/NCT00071422

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress